Clinical evidence suggests mutated 14-3-3γ diminishes its functionality, potentially leading to pathogenesis of DEE, a severe neurodevelopmental disorder characterized by early-onset epilepsy, cognitive impairments, and developmental delays (Guella et al., 2017; Kanani et al., 2020). This evidence concerns the gene YWHAG and epilepsy, early-onset.